Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 875 | 1,265 | 754 | 1,301 | 849 |
| Cost of Goods | 417 | 907 | 427 | 854 | 528 |
| Gross Profit | 459 | 358 | 327 | 447 | 322 |
| Operating Expenses | 1,246 | 1,555 | 1,324 | 1,591 | 1,171 |
| Operating Income | -788 | -1,197 | -996 | -1,144 | -850 |
| Interest Expense | 12 | 13 | 15 | 19 | 159 |
| Other Income | -2,634 | -230 | -220 | 96 | -442 |
| Pre-tax Income | -3,433 | -1,440 | -1,232 | -1,067 | -1,451 |
| Income Tax | -234 | -29 | -42 | -21 | -83 |
| Net Income Continuous | -3,198 | -1,411 | -1,190 | -1,046 | -1,368 |
| Minority Interests | 670 | 32 | 23 | 17 | 168 |
| Net Income | $-2,528 | $-1,379 | $-1,167 | $-1,028 | $-1,200 |
| EBITDA(a) | $-3,342 | $-1,342 | $-1,118 | $-952 | $-1,182 |